ArticleTheranostics2020
Monitoring innate immune cell dynamics in the glioma microenvironment by magnetic resonance imaging and multiphoton microscopy (MR-MPM).
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 41 citations in OpenAlex.
- Voxel-accurate MRI-microscopy Correlation Enables AI-powered Prediction of Brain Disease States.Theranostics · 2026Article
- Alveolar macrophages initiate the spatially targeted recruitment of neutrophils after nanoparticle inhalation.Science advances · 2025Article
- Three-photon microscopy: an emerging technique for deep intravital brain imaging.Nature reviews. Neuroscience · 2025Review
- Current advance of nanotechnology in diagnosis and treatment for malignant tumors.Signal transduction and targeted therapy · 2024Review
- Loading monocytes with magnetic nanoparticles enables their magnetic control without toxicity.Frontiers in bioengineering and biotechnology · 2024Article
- T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles.Nature communications · 2023Article
- PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma.Cancer gene therapy · 2023Article
- IONPs-Based Medical Imaging in Cancer Care: Moving Beyond Traditional Diagnosis and Therapeutic Assessment.International journal of nanomedicine · 2023Review
- Multimodal imaging of the dynamic brain tumor microenvironment during glioblastoma progression and in response to treatment.iScience · 2022Article
- Metal-Based Nanostructured Therapeutic Strategies for Glioblastoma Treatment-An Update.Biomedicines · 2022Review
- Integrated MRI-Immune-Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma.Cancers · 2022Article
- Association of the collagen signature with pathological complete response in rectal cancer patients.Cancer science · 2022Article
- Multiphoton Microscopy Reveals DAPK1-Dependent Extracellular Matrix Remodeling in a Chorioallantoic Membrane (CAM) Model.Cancers · 2022Article
- Probing immune infiltration dynamics in cancer by in vivo imaging.Current opinion in chemical biology · 2022Review
- Design of Magnetic Nanoplatforms for Cancer Theranostics.Biosensors · 2022Review
- Temporal radiographic and histological study of necrosis development in a mouse glioblastoma model.Frontiers in oncology · 2022Article
- Macrophages/Microglia in the Glioblastoma Tumor Microenvironment.International journal of molecular sciences · 2021Review
- 3D Whole-Brain Imaging Approaches to Study Brain Tumors.Cancers · 2021Review
- Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.Theranostics · 2021Article
- Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics.Theranostics · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 5 institutions in 2 countries.
Kianush Karimian-JaziNeuroradiology Department, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Philipp MünchNeuroradiology Department, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Allen AlexanderNeuroradiology Department, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Manuel FischerNeuroradiology Department, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Kira PfleidererNeuroradiology Department, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Manuel PiechuttaClinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Matthia A KarremanClinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Gergely M SoleckiClinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Anna S BerghoffClinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Mirco FriedrichClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Katrin DeumelandtClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Felix T KurzNeuroradiology Department, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Wolfgang WickClinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Sabine HeilandNeuroradiology Department, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Martin BendszusNeuroradiology Department, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Frank WinklerClinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK) within the German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Michael PlattenClinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Michael O BreckwoldtNeuroradiology Department, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Heidelberg University · DEUniversity Hospital Heidelberg · DEGerman Cancer Research Center · DEMedical University of Vienna · ATNational Center for Tumor Diseases · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsBlood-Brain BarrierBrain NeoplasmsCell TrackingGliomaImmunity, InnateImmunotherapyMacrophagesMagnetic Iron Oxide NanoparticlesMiceMice, Inbred C57BLMicrogliaMicroscopy, Fluorescence, MultiphotonNanoparticlesTumor Microenvironmentimmunotherapy.iron oxide nanoparticlesMRImultiphoton microscopytumor-associated macrophagestumor microenvironment
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.